1. Adil A, Koritala T, Munakomi S, Singh AK. Neurofibromatosis Type 1. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Thoyaja Koritala declares no relevant financial relationships with ineligible companies. Disclosure: Sunil Munakomi declares no relevant financial relationships with ineligible companies. Disclosure: Achint Singh declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC. 2024.
2. Le C, Bedocs PM. Neurofibromatosis. 2017.
3. Kotamarti VS, Feintisch AM, Datiashvili RO. Large Neurofibroma of the Face. Eplasty. 2015;15:ic36.
4. Ali SR, Hendrickson SA, Collin G, Oxley J, Warr RP. Solitary neurofibroma of the face masquerading as a low-flow vascular malformation - case report and experience of management. JPRAS Open. 2019;19:67-72. [
DOI:10.1016/j.jpra.2018.12.003]
5. Hillier JC, Moskovic E. The soft-tissue manifestations of neurofibromatosis type 1. Clinical Radiology. 2005;60(9):960-7. [
DOI:10.1016/j.crad.2005.02.008]
6. Botti G, Botti C. Midface lift: our current approaches. Handchirurgie· Mikrochirurgie· Plastische Chirurgie. 2014;46(4):224-33. [
DOI:10.1055/s-0034-1385927]
7. Pérez P, Hohman MH. Mid Face Facelift. Treasure Island (FL): StatPearls Publishing. 2024.
8. Joshi K, Hohman MH, Seiger E. SMAS plication facelift. 2018.
9. Park DM. Total facelift: forehead lift, midface lift, and neck lift. Archives of plastic surgery. 2015;42(2):111-25. [
DOI:10.5999/aps.2015.42.2.111]
10. Marten TJ, Elyassnia D. 63 - Forehead Lift. In: Farhadieh RD, Bulstrode NW, Mehrara BJ, Cugno S, editors. Plastic Surgery - Principles and Practice: Elsevier. 2022;973-1007. [
DOI:10.1016/B978-0-323-65381-7.00063-0]
11. Fattahi T. Trichophytic brow lift: a modification. Int J Oral Maxillofac Surg. 2015;44(3):371-3. [
DOI:10.1016/j.ijom.2014.10.007]
12. Dogra BB, Rana KS. Facial plexiform neurofibromatosis: A surgical challenge. Indian dermatology online journal. 2013;4(3):195-8. [
DOI:10.4103/2229-5178.115515]
13. Poplausky D, Young JN, Tai H, Rivera-Oyola R, Gulati N, Brown RM. Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments. Cancers. 2023;15(10):2770. [
DOI:10.3390/cancers15102770]
14. Chamseddin BH, Le LQ. Management of cutaneous neurofibroma: current therapy and future directions. Neuro-oncology advances. 2020;2(Suppl 1):i107-16. [
DOI:10.1093/noajnl/vdz034]
15. Singhal D, Chen Y-C, Tsai Y-J, Yu C-C, Chen HC, Chen Y-R, et al. Craniofacial Neurofibromatosis: Treatment of the midface deformity. J Craniomaxillofac Surg.2014;42(5):595-600. [
DOI:10.1016/j.jcms.2013.07.032]